These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 9077618

  • 1. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
    Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW.
    Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
    Branch DW, Silver R, Pierangeli S, van Leeuwen I, Harris EN.
    Obstet Gynecol; 1997 Apr; 89(4):549-55. PubMed ID: 9083311
    [Abstract] [Full Text] [Related]

  • 3. Variable effects on murine pregnancy of immunoglobulin G fractions from women with antiphospholipid antibodies.
    Silver RM, Smith LA, Edwin SS, Oshiro BT, Scott JR, Branch DW.
    Am J Obstet Gynecol; 1997 Jul; 177(1):229-33. PubMed ID: 9240611
    [Abstract] [Full Text] [Related]

  • 4. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
    Lee RM, Branch DW, Silver RM.
    Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809
    [Abstract] [Full Text] [Related]

  • 5. Anti-beta2-glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death, and antiphospholipid syndrome.
    Lee RM, Emlen W, Scott JR, Branch DW, Silver RM.
    Am J Obstet Gynecol; 1999 Sep; 181(3):642-8. PubMed ID: 10486478
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid antibodies and fetal death.
    Oshiro BT, Silver RM, Scott JR, Yu H, Branch DW.
    Obstet Gynecol; 1996 Apr; 87(4):489-93. PubMed ID: 8602296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The association between antiphospholipid antibodies and late fetal loss: A systematic review and meta-analysis.
    Xu J, Chen D, Duan X, Li L, Tang Y, Peng B.
    Acta Obstet Gynecol Scand; 2019 Dec; 98(12):1523-1533. PubMed ID: 31131876
    [Abstract] [Full Text] [Related]

  • 10. Anticardiolipin antibodies: clinical consequences of "low titers".
    Silver RM, Porter TF, van Leeuween I, Jeng G, Scott JR, Branch DW.
    Obstet Gynecol; 1996 Apr; 87(4):494-500. PubMed ID: 8602297
    [Abstract] [Full Text] [Related]

  • 11. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies.
    Rai RS, Clifford K, Cohen H, Regan L.
    Hum Reprod; 1995 Dec; 10(12):3301-4. PubMed ID: 8822463
    [Abstract] [Full Text] [Related]

  • 12. The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae.
    van der Spuy ZM, Bird AR, Lindow SW, Bruce C.
    S Afr Med J; 1993 May; 83(5):319-21. PubMed ID: 8211423
    [Abstract] [Full Text] [Related]

  • 13. Antiphospholipid antibodies other than lupus anticoagulant and anticardiolipin antibodies in women with recurrent pregnancy loss, fertile controls, and antiphospholipid syndrome.
    Rote NS.
    Obstet Gynecol; 1997 Oct; 90(4 Pt 1):642-4. PubMed ID: 9380335
    [No Abstract] [Full Text] [Related]

  • 14. Antiphospholipid and antioangiogenic activity in females with recurrent miscarriage and antiphospholipid syndrome.
    Pelusa HF, Pezzarini E, Basiglio CL, Musuruana J, Bearzotti M, Svetaz MJ, Daniele SM, Bottai H, Arriaga SM.
    Ann Clin Biochem; 2017 Sep; 54(5):577-583. PubMed ID: 27638930
    [Abstract] [Full Text] [Related]

  • 15. The association of antiphospholipid antibodies with intrauterine fetal death: a case-control study.
    Helgadottir LB, Skjeldestad FE, Jacobsen AF, Sandset PM, Jacobsen EM.
    Thromb Res; 2012 Jul; 130(1):32-7. PubMed ID: 22178574
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems.
    Aoki K, Dudkiewicz AB, Matsuura E, Novotny M, Kaberlein G, Gleicher N.
    Am J Obstet Gynecol; 1995 Mar; 172(3):926-31. PubMed ID: 7892887
    [Abstract] [Full Text] [Related]

  • 17. Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death.
    Al Jameil N, Tyagi P, Al Shenefy A.
    Int J Clin Exp Pathol; 2015 Mar; 8(3):3204-9. PubMed ID: 26045841
    [Abstract] [Full Text] [Related]

  • 18. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN, Pierangeli SS.
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [Abstract] [Full Text] [Related]

  • 19. [Antiphospholipid syndrome in females with recurrent fetal losses].
    Krysova LA, Lesniak OM, Putilova NV, Remizova II.
    Klin Med (Mosk); 1999 Apr; 77(7):43-6. PubMed ID: 10483165
    [Abstract] [Full Text] [Related]

  • 20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.